Cargando…
Network Meta-Analysis on the Effects of SGLT2 Inhibitors Versus Finerenone on Cardiorenal Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819058/ https://www.ncbi.nlm.nih.gov/pubmed/35140602 http://dx.doi.org/10.3389/fphar.2021.751496 |
| _version_ | 1784645970727796736 |
|---|---|
| author | Zhao, Li-Min Zhan, Ze-Lin Ning, Jie Qiu, Mei |
| author_facet | Zhao, Li-Min Zhan, Ze-Lin Ning, Jie Qiu, Mei |
| author_sort | Zhao, Li-Min |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8819058 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88190582022-02-08 Network Meta-Analysis on the Effects of SGLT2 Inhibitors Versus Finerenone on Cardiorenal Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease Zhao, Li-Min Zhan, Ze-Lin Ning, Jie Qiu, Mei Front Pharmacol Pharmacology Frontiers Media S.A. 2022-01-24 /pmc/articles/PMC8819058/ /pubmed/35140602 http://dx.doi.org/10.3389/fphar.2021.751496 Text en Copyright © 2022 Zhao, Zhan, Ning and Qiu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Zhao, Li-Min Zhan, Ze-Lin Ning, Jie Qiu, Mei Network Meta-Analysis on the Effects of SGLT2 Inhibitors Versus Finerenone on Cardiorenal Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease |
| title | Network Meta-Analysis on the Effects of SGLT2 Inhibitors Versus Finerenone on Cardiorenal Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease |
| title_full | Network Meta-Analysis on the Effects of SGLT2 Inhibitors Versus Finerenone on Cardiorenal Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease |
| title_fullStr | Network Meta-Analysis on the Effects of SGLT2 Inhibitors Versus Finerenone on Cardiorenal Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease |
| title_full_unstemmed | Network Meta-Analysis on the Effects of SGLT2 Inhibitors Versus Finerenone on Cardiorenal Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease |
| title_short | Network Meta-Analysis on the Effects of SGLT2 Inhibitors Versus Finerenone on Cardiorenal Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease |
| title_sort | network meta-analysis on the effects of sglt2 inhibitors versus finerenone on cardiorenal outcomes in patients with type 2 diabetes and chronic kidney disease |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819058/ https://www.ncbi.nlm.nih.gov/pubmed/35140602 http://dx.doi.org/10.3389/fphar.2021.751496 |
| work_keys_str_mv | AT zhaolimin networkmetaanalysisontheeffectsofsglt2inhibitorsversusfinerenoneoncardiorenaloutcomesinpatientswithtype2diabetesandchronickidneydisease AT zhanzelin networkmetaanalysisontheeffectsofsglt2inhibitorsversusfinerenoneoncardiorenaloutcomesinpatientswithtype2diabetesandchronickidneydisease AT ningjie networkmetaanalysisontheeffectsofsglt2inhibitorsversusfinerenoneoncardiorenaloutcomesinpatientswithtype2diabetesandchronickidneydisease AT qiumei networkmetaanalysisontheeffectsofsglt2inhibitorsversusfinerenoneoncardiorenaloutcomesinpatientswithtype2diabetesandchronickidneydisease |